Chen Long, Huang Yu-Li, Liu Fang, Huang Nan, Zeng Ding-Cheng, Zhong Yan-Biao, Liao Jing-Hai, Wang Mao-Yuan
Department of Rehabilitation Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
School of Rehabilitation, Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
Patient Prefer Adherence. 2025 Aug 25;19:2623-2633. doi: 10.2147/PPA.S538773. eCollection 2025.
Cardiovascular disease (CVD) poses a significant health burden in middle-aged and older Chinese populations, with Chinese herbal medicine (CHM) often used as a complementary therapy. This study aimed to analyze the characteristics of CHM use and its influencing factors in middle-aged and older Chinese patients with CVD.
This was a cross-sectional study based on data from the 2018 China Health and Aging Longitudinal Study (CHARLS). We surveyed 4511 patients with CVD, aged 45 years or older, who reported using CHM to analyze their demographic characteristics, healthcare utilization, and health status.
Approximately 24.05% (1085/4511) of the participants reported managing CVD with CHM. Compared with non-users, CHM users were older (OR=1.21; 95% CI=1.04-1.40), more educated (OR=1.30; 95% CI=1.08-1.57), more likely to reside in a city (OR=1.19; 95% CI=1.01-1.41), and were associated with visiting a Chinese medicine hospital (OR=1.17; 95% CI=1.01-1.37), self-medication (OR=1.48; 95% CI=1.24-1.77), poor health (OR=1.52; 95% CI=1.17-1.98), comorbidities such as kidney disease (OR=1.34; 95% CI=1.02-1.75), asthma (OR=1.67; 95% CI=1.21-2.32), and emotional problems (OR=1.98; 95% CI=1.28-3.07). In an additional interaction analysis, patients with urban residence and mood problems were most likely to use CHM (OR=6.93, 95% CI: 1.77-27.19).
Factors contributing to CHM use in middle-aged and older patients with CVD are multifaceted, encompassing demographic characteristics, health service, and health status.
心血管疾病(CVD)给中国中老年人群带来了沉重的健康负担,中药(CHM)常被用作辅助治疗方法。本研究旨在分析中国中老年心血管疾病患者使用中药的特征及其影响因素。
这是一项基于2018年中国健康与养老追踪调查(CHARLS)数据的横断面研究。我们对4511名年龄在45岁及以上且报告使用中药的心血管疾病患者进行了调查,以分析他们的人口统计学特征、医疗服务利用情况和健康状况。
约24.05%(1085/4511)的参与者报告使用中药来管理心血管疾病。与未使用者相比,使用中药的患者年龄更大(OR = 1.21;95% CI = 1.04 - 1.40),受教育程度更高(OR = 1.30;95% CI = 1.08 - 1.57),更有可能居住在城市(OR = 1.19;95% CI = 1.01 - 1.41),并且与就诊于中医医院(OR = 1.17;95% CI = 1.01 - 1.37)、自我用药(OR = 1.48;95% CI = 1.24 - 1.77)、健康状况较差(OR = 1.52;95% CI = 1.17 - 1.98)、患有肾病(OR = 1.34;95% CI = 1.02 - 1.75)、哮喘(OR = 1.67;95% CI = 1.21 - 2.32)和情绪问题(OR = 1.98;95% CI = 1.28 - 3.07)等合并症有关。在一项额外的交互分析中,居住在城市且有情绪问题的患者最有可能使用中药(OR = 6.93,95% CI:1.77 - 27.19)。
导致中国中老年心血管疾病患者使用中药的因素是多方面的,包括人口统计学特征、医疗服务和健康状况。